Advanced diagnostic and prognostic solutions for urological cancer care 

No matter which test(s) you receive from our growing portfolio of traditional and breakthrough products and services, rest assured they are backed by our superior clinical expertise and the
highest level of customer support.

Press Release

New Data Demonstrates ProMark™ Accurately Predicts Prostate Cancer Aggressiveness and Pathological Outcomes

ProMark™ has Potential to Transform Prostate Cancer Care by Aiding Doctors and Patients with Appropriate Treatment Assessment

read article
Press Release

METAMARK GENETICS RECEIVES LABORATORY LICENSE IN PREPARATION TO LAUNCH ProMark™ PROSTATE-CANCER ASSAY

Metamark Genetics, Inc. today announced that its Cambridge, Mass. laboratory has been licensed for the highest level of clinical testing in the use of ProMark™, the company's prognostic assay to guide the medical management of patients with prostate cancer.

read article
Displaying results 11-12 (of 12)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 >  >|